This shift brings new responsibilities and opportunities, from managing inventory changes to counseling patients on alternative therapies.
With the help of new and complex algorithms and self-learning models, we are currently privy to what we may look back on as the golden era of AI.
Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
Remember the words of Nelson Mandela: "It always seems impossible until it's done."
Some of the most frequently noted biotin interferences are with immunoassays for thyroid markers, high-sensitivity cardiac troponin, and N-terminal pro-brain natriuretic peptide.
Panelists discuss how pharmacists play a crucial role in biliary tract cancer management by leveraging their detailed medication knowledge to assist with treatment selection, develop comprehensive monitoring plans (especially for hyperphosphatemia with FGFR inhibitors and cardiac monitoring with HER2 therapies), educate patients about unique toxicities and self-management strategies, create clinic workflow algorithms for toxicity management, and advocate for maximizing time on therapy as long as patients maintain response or stable disease given the limited treatment options available for this rare cancer type.
Without a constitutional right to abortion, mail order pharmacy providers need to consider both the federal requirements and various state laws in how they approach the dispensing of mifepristone across state lines.
An effective therapeutic treatment for acute or chronic pain needs to be convenient, easy to self-administer, and have rapid onset to provide fast relief.
While larger pharmacies can utilize a network of clinical resources, smaller community pharmacies are embracing their relationships with their local communities.
Although cholesterol-lowering guidance often touts the achievement of very low levels of low-density lipoprotein (LDL) cholesterol, emerging research demonstrates possible safety risks.
These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.
Leaders must fully understand the benefits of diversity and create an environment in which it thrives to cultivate and inspire the next generation of inclusive leaders.
Christian John Lillis reflects on key insights from the 2025 Peggy Lillis Foundation C diff Summit, highlighting the critical role of pharmacists in infectious disease care, persistent challenges in patient outcomes, and the need for renewed investment in public health infrastructure and policy.
AI models can predict pharmacy foot traffic and peak service times, and even analyze patient histories to single out who picks up their prescriptions on time.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
Sarah Rockwell, PharmD, BCOP, and Ke Ning, MD, share their concluding remarks, reflecting on the current landscape and expressing their aspirations for addressing remaining unmet needs.
With the current social media trend of the “Sleepy-Girl Mocktail” claiming to provide quality sleep, is this trend fact or faux as a quality sleep aid?
The plan first addresses monoclonal antibodies but could eventually be applied to all compounds seeking FDA approval.
As one of the most trusted health care professionals, pharmacists play a vital role in debunking medication myths by providing patients with accurate information to make positive decisions regarding their health.
Andrew Charles, MD, outlines why calcitonin-gene-related peptide (CGRP) antagonists are increasingly favored as first-line migraine treatments and how pharmacists play a key role in patient education and support.
The panel discussion concludes with final thoughts on the future landscape of newly diagnosed multiple myeloma.
Benefits of a preassessment include evaluation, benchmarking, and improved patient safety.
A pharmacist-led transitions of care program reduced chronic obstructive pulmonary disease readmissions by implementing guideline-based inhaler prescribing and addressing medication adherence barriers, decreasing 30-day readmission rates.
Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.
Pharmacists working with long-term care centers benefit from streamlined billing to support and build patient trust.
Abemaciclib and ribociclib have various risks and benefits in treating early breast cancer, highlighting the importance of patient-provider communication.
High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.
Artificial intelligence (AI) is transforming drug development by automating routine tasks, enhancing clinical trials, and expediting drug discovery, ultimately leading to more personalized treatments.